TWIST1 hypermethylation is observed in pancreatic cancer

Sen-Yo,Manabu; Suehiro,Yutaka; Kaino,Seiji; Sakaida,Isao

doi:10.3892/br.2012.25

January-February 2013 Volume 1 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

January-February 2013 Volume 1 Issue 1

Full Size Image

Article

TWIST1 hypermethylation is observed in pancreatic cancer

Authors:
- Manabu Sen-Yo
- Yutaka Suehiro
- Seiji Kaino
- Isao Sakaida
View Affiliations / Copyright

Affiliations: Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755-8505, Japan, Department of Oncology and Laboratory Medicine, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755-8505, Japan
Pages: 31-33
|
Published online on: October 18, 2012

https://doi.org/10.3892/br.2012.25
Expand metrics +

Abstract

Despite the growing evidence demonstrating that TWIST1 is a noteworthy tumor biomarker, little is known about the clinical significance of TWIST1 methylation in human primary pancreatic cancer. In the present study, the association of TWIST1 methylation with clinicopathological characteristics was examined in human primary pancreatic cancer. Primary pancreatic cancer specimens and corresponding healthy pancreatic non‑tumorous tissues from 33 patients with pancreatic cancer were used. Methylation levels of TWIST1 were compared with clinicopathological characteristics. The TWIST1 methylation level was higher in pancreatic cancer compared to corresponding non‑neoplastic pancreatic tissues. The mean TWIST1 methylation was 66.7% for pancreatic cancer tissue and 15.0% for corresponding nonneoplastic pancreatic tissue (P=0.0004). These results suggested that TWIST1 methylation is a useful biomarker for the screening of pancreatic cancers. Studies using independent data sets are required to confirm these findings.

View Figures

View References

1.	Warshaw AL and Fernandez-del Castillo C: Pancreatic carcinoma. N Engl J Med. 326:455–465. 1992. View Article : Google Scholar : PubMed/NCBI
2.	Niederhuber JE, Brennan MF and Menck HR: The National Cancer Data Base report on pancreatic cancer. Cancer. 76:1671–1677. 1995. View Article : Google Scholar : PubMed/NCBI
3.	Hebrok M, Wertz K and Fuchtbauer EM: M-twist is an inhibitor of muscle differentiation. Dev Biol. 165:537–544. 1994. View Article : Google Scholar : PubMed/NCBI
4.	Chen ZF and Behringer RR: Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev. 9:686–699. 1995. View Article : Google Scholar : PubMed/NCBI
5.	Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002. View Article : Google Scholar : PubMed/NCBI
6.	Selamat SA, Galler JS, Joshi AD, et al: DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma. PloS One. 6:e214432011. View Article : Google Scholar : PubMed/NCBI
7.	Missaoui N, Hmissa S, Trabelsi A, et al: Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix. Pathol Res Prac. 207:37–42. 2011. View Article : Google Scholar : PubMed/NCBI
8.	Renard I, Joniau S, van Cleynenbreugel B, et al: Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples. Eur Urol. 58:96–104. 2010. View Article : Google Scholar
9.	Okada T, Suehiro Y, Ueno K, et al: TWIST1 hypermethylation is observed frequently in colorectal tumors and its overexpression is associated with unfavorable outcomes in patients with colorectal cancer. Genes Chromosomes Cancer. 49:452–462. 2010.PubMed/NCBI
10.	Suehiro Y, Wong CW, Chirieac LR, et al: Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. Clin Cancer Res. 14:2560–2569. 2008. View Article : Google Scholar : PubMed/NCBI
11.	Santini V, Kantarjian HM and Issa JP: Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Inter Med. 134:573–586. 2001. View Article : Google Scholar : PubMed/NCBI
12.	Ohuchida K, Mizumoto K, Ohhashi S, et al: Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice. Int J Cancer. 120:1634–1640. 2007. View Article : Google Scholar : PubMed/NCBI
13.	Gort EH, Suijkerbuijk KP, Roothaan SM, et al: Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer. Cancer Epidemiol Biomarkers Prev. 17:3325–3330. 2008. View Article : Google Scholar : PubMed/NCBI
14.	Gort EH, van Haaften G, Verlaan I, et al: The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha. Oncogene. 27:1501–1510. 2008. View Article : Google Scholar : PubMed/NCBI
15.	Yang MH, Wu MZ, Chiou SH, et al: Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol. 10:295–305. 2008. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

TWIST1 hypermethylation is observed in pancreatic cancer

This article is mentioned in:

Abstract

Figure 1

Related Articles